As of July 2026, 117 paid clinical trials are recruiting in Irving, Texas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Irving offers studies at sites including NEXT Dallas for conditions such as Advanced Solid Tumors, Advanced Solid Tumor, Colorectal Cancer, Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Researchers run research studies in Irving, TX at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| NEXT Dallas | Advanced Solid Tumors, Colorectal Cancer, Cancer | 19 |
| NEXT Oncology | Advanced-stage Solid Tumors, Cancer, Cervical Adenocarcinoma | 10 |
| US Oncology Investigational Products Center (IPC) | Colorectal Neoplasms, Non-Small Cell Lung Cancer, Advanced Non-Small Cell Lung Cancer | 9 |
| NEXT Oncology Dallas | Colorectal Cancer, Mesothelioma, Pancreatic Ductal Adenocarcinoma | 9 |
| US Oncology Investigational Product Center (IPC) | Breast Cancer, Advanced/Metastatic Urothelial Cancer, Breast Neoplasms | 8 |
| NEXT Oncology - Dallas | Advanced Solid Tumors, CNS Tumor, CRC | 7 |
| US Oncology Investigational Products Center | Advanced Non-Small Cell Lung Cancer, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 4 |
| Texas Center for Proton Therapy | Cancer, Neoplasms, Pediatric Patients Treated With Radiation Therapy | 3 |
| US Oncology Research Investigational Products Center | Extensive Stage Small-cell Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer | 3 |
| NEXT Dallas - Oncology Department | Advanced/Metastatic Colorectal Adenocarcinoma, MTAP-deleted Solid Tumors | 2 |
| Next Dallas | Advanced Solid Tumor, Advanced Breast Cancer, HER2-negative Breast Cancer | 2 |
| Precision Comprehensive Clinical Research Solutions | Rheumatoid Arthritis | 2 |
| Seaport Investigator Site | Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress | 2 |
| AARA Clinical Research - Lone Star Arthritis and Rheumatology Associates - Irving | Overweight or Obesity, Psoriatic Arthritis, Radiographic Axial Spondyloarthritis | 2 |
| NEXT Oncology - Irving | Breast Cancer, Lung Cancer, Advanced Squamous Tumors | 2 |
| 015 | Advanced Solid Tumor | 1 |
| AARA Clinical Research Lone Star Arthritis and Rheumatology | Arthritis, Psoriatic | 1 |
| ALS Global | Atopic Dermatitis, Eczema, Eczema Atopic Dermatitis | 1 |
| Artiva Investigational | IIM, Idiopathic Inflammatory Myopathies (IIMs), Myositis | 1 |
| Avenzo Therapeutics Recruiting Site | Locally Advanced, Metastatic Solid Tumors, Solid Tumor Cancer | 1 |
| Baylor - Christus Children's - Main Hospital | Failed or Difficult Intubation, Sequela, Intubation Complication, Intubation; Difficult | 1 |
| Clinical Study | Obesity, Overweight, Weight Maintenance | 1 |
| Crinetics Study Site | Neuroendocrine Neoplasm, Neuroendocrine Tumors, SST2-positive Neuroendocrine Neoplasms | 1 |
| DM Clinical - Dallas | HOMA-IR, Mobility Disability, Obesity & Overweight | 1 |
| DM Clinical Research - Irving | Heart Failure | 1 |
Recruiting trials in Irving grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 117 recruiting clinical trials in Irving, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Irving compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Irving include Advanced Solid Tumors (10), Advanced Solid Tumor (7), Colorectal Cancer (7), Breast Cancer (5), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Irving on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Irving include NEXT Dallas, NEXT Oncology, US Oncology Investigational Products Center (IPC), among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Irving are Cancer & tumors (57), Diabetes & metabolic (6), Mental health & behavior (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.